Lisa M Baumann Kreuziger, MD, MS | Medical College of Wisconsin

Lisa M. Baumann Kreuziger, MD, MS

Associate Professor

view physician profile

Locations

Froedtert Hospital
Cancer Center - Froedtert Menomonee Falls Hospital

Specialties

Hematology

Languages

English

Education

MD - Doctor of Medicine
MS -Master of Science

Biography

Lisa Baumann Kreuziger, MD is an Associate Medical Director at the Versiti Blood Center of Wisconsin and Assistant Professor at the Medical College of Wisconsin - Division of Hematology and Oncology. She specializes in the treatment of clotting disorders and other benign hematology diseases. Dr. Baumann Kreuziger is a native of Wisconsin and graduated from medical school at University of Wisconsin-Madison. She completed her Internal Medicine residency at Mayo Clinic where she was a Chief Resident. Dr. Baumann Kreuziger attended Hematology and Oncology fellowship at the University of Minnesota and completed clinical research training on the NIH Hematology Training grant.

The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.

(Josephson CD, Glynn S, Mathew S, Birch R, Bakkour S, Baumann Kreuziger L, Busch MP, Chapman K, Dinardo C, Hendrickson J, Hod EA, Kelly S, Luban N, Mast A, Norris P, Custer B, Sabino E, Sachais B, Spencer BR, Stone M, Kleinman S, National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P).) Transfusion. 2022 05;62(5):982-999 PMID: 35441384 SCOPUS ID: 2-s2.0-85128417061 04/21/2022
Risk of venous thromboembolism after COVID-19 vaccination.

(Houghton DE, Wysokinski W, Casanegra AI, Padrnos LJ, Shah S, Wysokinska E, Pruthi R, Ashrani A, Sridharan M, Baumann-Kreuziger L, McBane R, Padmanabhan A.) J Thromb Haemost. 2022 Apr 10 PMID: 35398975 PMCID: PMC9115120 SCOPUS ID: 2-s2.0-85128433811 04/11/2022
Catheter-based system for the treatment of left ventricular assist device thrombosis.

(Joyce DL, Lynch BE, Freed J, Kreuziger LB, Salinger MH, Joyce LD.) Artif Organs. 2022 Apr;46(4):705-709 PMID: 35080023 SCOPUS ID: 2-s2.0-85124909222 01/27/2022
A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal.

(Baumann Kreuziger L, Feng M, Bartosic A, Simpson P, Wang TF.) Blood Coagul Fibrinolysis. 2022 Apr 01;33(3):171-175 PMID: 34980834 SCOPUS ID: 2-s2.0-85131270118 01/05/2022
Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical Support.

(Levy JH, Faraoni D, Almond CS, Baumann-Kreuziger L, Bembea MM, Connors JM, Dalton HJ, Davies R, Dumont LJ, Griselli M, Karkouti K, Massicotte MP, Teruya J, Thiagarajan RR, Spinella PC, Steiner ME.) Ann Thorac Surg. 2022 03;113(3):1026-1035 PMID: 34826386 SCOPUS ID: 2-s2.0-85122933455 11/27/2021
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

(Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B, Berry S, Bochicchio G, de Oliveira Antunes M, Farkouh ME, Greenstein Y, Hade EM, Hudock K, Hyzy R, Khatri P, Kindzelski A, Kirwan BA, Baumann Kreuziger L, Lawler PR, Leifer E, Lopez-Sendon Moreno J, Lopez-Sendon J, Luther JF, Nigro Maia L, Quigley J, Sherwin R, Wahid L, Wilson J, Hochman JS, Neal MD, ACTIV-4a Investigators.) JAMA. 2022 01 18;327(3):227-236 PMID: 35040887 PMCID: PMC8767444 SCOPUS ID: 2-s2.0-85123380504 01/19/2022
Symptomatic pulmonary embolus after catheter removal in children with catheter related thrombosis: A report from the CHAT Consortium.

(Jaffray J, Baumann Kreuziger L, Branchford B, Wee CP, Faustino EVS, Zakai NA, Croteau SE, Silvey M, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Goldenberg NA.) J Thromb Haemost. 2022 01;20(1):133-137 PMID: 34623749 SCOPUS ID: 2-s2.0-85117177584 10/09/2021
Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.

(Carney BJ, Wang TF, Ren S, George G, Al Homssi A, Gaddh M, Connolly GC, Shah VI, Bogue T, Bartosic A, Neuberg D, Baumann Kreuziger L, Zwicker JI, VENUS Network Investigators.) Blood Adv. 2021 12 28;5(24):5546-5553 PMID: 34662892 PMCID: PMC8714719 SCOPUS ID: 2-s2.0-85122382533 10/19/2021
Randomized trials of therapeutic heparin for COVID-19: A meta-analysis.

(Sholzberg M, da Costa BR, Tang GH, Rahhal H, AlHamzah M, Baumann Kreuziger L, Ní Áinle F, Almarshoodi MO, James PD, Lillicrap D, Carrier M, Beckett A, Fralick M, Middeldorp S, Lee AYY, Thorpe KE, Negri EM, Cushman M, Jüni P, RAPID Trial Investigators.) Res Pract Thromb Haemost. 2021 Dec;5(8):e12638 PMID: 34977448 PMCID: PMC8681879 01/04/2022
Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study.

(Kamin Mukaz D, Gergi M, Koh I, Zakai NA, Judd SE, Sholzberg M, Baumann Kreuziger L, Freeman K, Colovos C, Olson NC, Cushman M.) Res Pract Thromb Haemost. 2021 Dec;5(8):e12632 PMID: 34934895 PMCID: PMC8652130 12/23/2021
Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study

(Kamin Mukaz D, Gergi M, Koh I, Zakai NA, Judd SE, Sholzberg M, Baumann Kreuziger L, Freeman K, Colovos C, Olson NC, Cushman M.) Research and Practice in Thrombosis and Haemostasis. December 2021;5(8) SCOPUS ID: 2-s2.0-85121813795 12/01/2021
Randomized trials of therapeutic heparin for COVID-19: A meta-analysis

(Sholzberg M, da Costa BR, Tang GH, Rahhal H, AlHamzah M, Baumann Kreuziger L, Ní Áinle F, Almarshoodi MO, James PD, Lillicrap D, Carrier M, Beckett A, Fralick M, Middeldorp S, Lee AYY, Thorpe KE, Negri EM, Cushman M, Jüni P.) Research and Practice in Thrombosis and Haemostasis. December 2021;5(8) SCOPUS ID: 2-s2.0-85122084631 12/01/2021